DEA Reschedules Hydrocodone Combination Products

Posted in Latest News on August 25, 2014.

On Friday, August 22nd, the U. S. Drug Enforcement Administration (DEA) published a Final Rule moving hydrocodone combination products (HCPs) from Schedule III to the more-restrictive Schedule II. This Final Rule imposes the regulatory controls and sanctions applicable to Schedule II substances on those who handle or propose to handle HCPs. The rule goes into effect 45 days from its publish date.



More Latest News

Attention Pharmacists: Florida HB423
March 13, 2017

ARNP’s and PA’s, if you have questions regarding the Florida House Bill 423 and how it affects you, this free, informative webinar is for you! Continue reading


Imagineering the Future of Pharmacy Regulation
March 2, 2017

The boards of pharmacy will elect officers and members of the NABP Executive Committee, review and vote on NABP policies, and guide the direction of the Association Continue reading